Reproducibility is a foundational element of the scientific method, a benchmark upon which the reliability of an experiment can be tested.
However the field is facing alarmingly high irreproducibility rate as illustrated in various industry publications, with reports ranging from 50% to 80% of published results not being reproducible. It has been estimated that in the United States alone approx. US$28B funding is spent on preclinical research that is not reproducible. This estimation does not even take into account the impact on delaying translational research and causing high failure rates observed for the development of new treatments.
The underlying causes can be debated but none hold for long. We cannot afford to lose time and money on irreproducible research any longer.
Facing the urgency, international consortia and collaborations between stakeholders including public-private partnerships were formed to exchange, develop and implement quality standards and best practices.

Ability Level: All

Session ID: 502001